Literature DB >> 17316381

Similar pattern in cardiac differentiation of human embryonic stem cell lines, BG01V and ReliCellhES1, under low serum concentration supplemented with bone morphogenetic protein-2.

Rajarshi Pal1, Aparna Khanna.   

Abstract

Human embryonic stem cells (hESCs) can differentiate into cardiomyocytes, but the efficiency of this process is highly variable. So, developing generic differentiation protocols and their empirical testing on a range of independently derived hESC lines pose a daunting challenge due to considerable diversity in culture methods practiced between lines. Maintenance of BG01V and ReliCellhES1 has routinely been on mouse embryonic fibroblast (MEF) feeder layers using manual passaging. We assessed cardiac differentiation from both the cell lines via embryoid body (EB) formation. Subsequent culture in low fetal bovine serum (5%)-containing medium produced spontaneously contracting EBs, in the presence of bone morphogenetic protein-2 (BMP-2; 25 ng/ml). Derived cardiomyocytes expressed cardiac genes and proteins and responded to functional assays. Further, the activation of the Smad signaling machinery evoked by BMP-2 has been confirmed through inhibitor studies. Therefore, in our hands, the same differentiation conditions functioned in two independently derived hESC lines. Similar studies in other lines may facilitate development of universal protocols. The present data may also provide valuable insights for testing of other factors that might promote cardiomyocyte differentiation in low-serum formulations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17316381     DOI: 10.1111/j.1432-0436.2006.00123.x

Source DB:  PubMed          Journal:  Differentiation        ISSN: 0301-4681            Impact factor:   3.880


  8 in total

1.  Timed inhibition of p38MAPK directs accelerated differentiation of human embryonic stem cells into cardiomyocytes.

Authors:  Meenakshi Gaur; Carissa Ritner; Rich Sievers; Anissa Pedersen; Megha Prasad; Harold S Bernstein; Yerem Yeghiazarians
Journal:  Cytotherapy       Date:  2010-10       Impact factor: 5.414

2.  Ghrelin promotes differentiation of human embryonic stem cells into cardiomyocytes.

Authors:  Jin Yang; Guo-qiang Liu; Rui Wei; Wen-fang Hou; Mei-juan Gao; Ming-xia Zhu; Hai-ning Wang; Gui-an Chen; Tian-pei Hong
Journal:  Acta Pharmacol Sin       Date:  2011-08-01       Impact factor: 6.150

Review 3.  Present state and future perspectives of using pluripotent stem cells in toxicology research.

Authors:  Anna M Wobus; Peter Löser
Journal:  Arch Toxicol       Date:  2011-01-12       Impact factor: 5.153

4.  Dopaminergic neurons derived from BG01V2, a variant of human embryonic stem cell line BG01.

Authors:  Tandis Vazin; Jia Chen; Charles E Spivak; Rose Amable; Emily Gabitzsch; Chun-Ting Lee; Carl R Lupica; William J Freed
Journal:  Restor Neurol Neurosci       Date:  2008       Impact factor: 2.406

Review 5.  Electrophysiological and contractile function of cardiomyocytes derived from human embryonic stem cells.

Authors:  Adriana Blazeski; Renjun Zhu; David W Hunter; Seth H Weinberg; Kenneth R Boheler; Elias T Zambidis; Leslie Tung
Journal:  Prog Biophys Mol Biol       Date:  2012-08-07       Impact factor: 3.667

Review 6.  Uses of cardiomyocytes generated from induced pluripotent stem cells.

Authors:  Tung-Ying Lu; Lei Yang
Journal:  Stem Cell Res Ther       Date:  2011-11-18       Impact factor: 6.832

7.  Use of long-term cultured embryoid bodies may enhance cardiomyocyte differentiation by BMP2.

Authors:  Yoon Young Kim; Seung-Yup Ku; Jiho Jang; Sun Kyung Oh; Hee Sun Kim; Seok Hyun Kim; Young Min Choi; Shin Yong Moon
Journal:  Yonsei Med J       Date:  2008-10-31       Impact factor: 2.759

8.  A comprehensive analysis of gene expression changes in a high replicate and open-source dataset of differentiating hiPSC-derived cardiomyocytes.

Authors:  Tanya Grancharova; Kaytlyn A Gerbin; Alexander B Rosenberg; Charles M Roco; Joy E Arakaki; Colette M DeLizo; Stephanie Q Dinh; Rory M Donovan-Maiye; Matthew Hirano; Angelique M Nelson; Joyce Tang; Julie A Theriot; Calysta Yan; Vilas Menon; Sean P Palecek; Georg Seelig; Ruwanthi N Gunawardane
Journal:  Sci Rep       Date:  2021-08-04       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.